ID   PER-604
AC   CVCL_W990
DR   Wikidata; Q54947211
RX   PubMed=17117183;
CC   Doubling time: 181 hours (PubMed=17117183).
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 11,12,17
ST   D19S433: 14,16.2
ST   D21S11: 30,31.2
ST   D2S1338: 24,25
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 20,21
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
RX   PubMed=17117183; DOI=10.1038/sj.bjc.6603447; PMCID=PMC2360743;
RA   Beesley, Alex H.
RA   Palmer, Misty-Lee
RA   Ford, Jette
RA   Weller, Richard E.
RA   Cummings, Aaron J.
RA   Freitas, Joseph R.
RA   Firth, Martin J.
RA   Perera, Kanchana U.
RA   de Klerk, Nick H.
RA   Kees, Ursula R.
RT   "Authenticity and drug resistance in a panel of acute lymphoblastic
RT   leukaemia cell lines.";
RL   Br. J. Cancer 95:1537-1544(2006).
//